Lydall Inc (LDL) 43.05 $LDL Lydall Acquires Texel, a

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Lydall Inc (LDL) 43.05 $LDL

Lydall Acquires Texel, a Leader in Innovative Technical Materials
GlobeNewswire - Fri Jul 08, 5:00AM CDT
- Strengthens Lydall's position as an industry leader in engineered materials
LDL: 43.05 (+0.04)

Lydall Up 38.8% Since SmarTrend Uptrend Call (LDL)
Comtex SmarTrend(R) - Wed Jul 06, 12:39AM CDT
SmarTrend identified an Uptrend for Lydall (NYSE:LDL) on February 23rd, 2016 at $27.73. In approximately 4 months, Lydall has returned 38.79% as of today's recent price of $38.48.
LDL: 43.05 (+0.04)

35.8% Return Seen to Date on SmarTrend Lydall Call (LDL)
Comtex SmarTrend(R) - Tue Jun 28, 1:04PM CDT
SmarTrend identified an Uptrend for Lydall (NYSE:LDL) on February 23rd, 2016 at $27.73. In approximately 4 months, Lydall has returned 35.80% as of today's recent price of $37.65.
LDL: 43.05 (+0.04)

Shares of LDL Up 41.9% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Jun 21, 12:39AM CDT
SmarTrend identified an Uptrend for Lydall (NYSE:LDL) on February 23rd, 2016 at $27.73. In approximately 4 months, Lydall has returned 41.86% as of today's recent price of $39.33.
LDL: 43.05 (+0.04)

Lydall Shares Up 37.0% Since SmarTrend's Buy Recommendation (LDL)
Comtex SmarTrend(R) - Mon Jun 13, 1:10PM CDT
SmarTrend identified an Uptrend for Lydall (NYSE:LDL) on February 23rd, 2016 at $27.73. In approximately 4 months, Lydall has returned 37.01% as of today's recent price of $37.99.
LDL: 43.05 (+0.04)

Shares of LDL Up 37.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri May 27, 12:40AM CDT
SmarTrend identified an Uptrend for Lydall (NYSE:LDL) on February 23rd, 2016 at $27.73. In approximately 3 months, Lydall has returned 37.82% as of today's recent price of $38.21.
LDL: 43.05 (+0.04)

Lydall Has Returned 32.7% Since SmarTrend Recommendation (LDL)
Comtex SmarTrend(R) - Thu May 19, 1:11PM CDT
SmarTrend identified an Uptrend for Lydall (NYSE:LDL) on February 23rd, 2016 at $27.73. In approximately 3 months, Lydall has returned 32.66% as of today's recent price of $36.78.
LDL: 43.05 (+0.04)

Lydall Announces Financial Results for the First Quarter Ended March 31, 2016
GlobeNewswire - Tue May 03, 3:30PM CDT
-- EPS of $0.54, up 29% from adjusted Q1 2015
LDL: 43.05 (+0.04)

Uptrend Call Working As Lydall Stock Rises 30.6% (LDL)
Comtex SmarTrend(R) - Tue Apr 26, 1:05PM CDT
SmarTrend identified an Uptrend for Lydall (NYSE:LDL) on February 23rd, 2016 at $27.73. In approximately 2 months, Lydall has returned 30.57% as of today's recent price of $36.20.
LDL: 43.05 (+0.04)

Lydall First Quarter Ended March 31, 2016 Earnings Release Conference Call Scheduled for May 4, 2016
GlobeNewswire - Tue Apr 19, 3:30PM CDT
Lydall, Inc. (NYSE:LDL) announced today that it will release its financial results for the first quarter ended March 31, 2016 on Tuesday, May 3, 2016 after the market closes. A conference call will be held on Wednesday, May 4, 2016 at 10:00 a.m. Eastern Time and be hosted by:
LDL: 43.05 (+0.04)

Lydall Up 27.6% Since SmarTrend Uptrend Call (LDL)
Comtex SmarTrend(R) - Tue Apr 19, 12:50AM CDT
SmarTrend identified an Uptrend for Lydall (NYSE:LDL) on February 23rd, 2016 at $27.73. In approximately 2 months, Lydall has returned 27.61% as of today's recent price of $35.38.
LDL: 43.05 (+0.04)

21.7% Return Seen to Date on SmarTrend Lydall Call (LDL)
Comtex SmarTrend(R) - Tue Apr 12, 12:18AM CDT
SmarTrend identified an Uptrend for Lydall (NYSE:LDL) on February 23rd, 2016 at $27.73. In approximately 2 months, Lydall has returned 21.73% as of today's recent price of $33.75.
LDL: 43.05 (+0.04)

Uptrend Call Working As Lydall Stock Rises 19.7% (LDL)
Comtex SmarTrend(R) - Mon Apr 04, 1:07PM CDT
SmarTrend identified an Uptrend for Lydall (NYSE:LDL) on February 23rd, 2016 at $27.73. In approximately 1 month, Lydall has returned 19.68% as of today's recent price of $33.18.
LDL: 43.05 (+0.04)

Lydall Down 20.1% Since SmarTrend Downtrend Call (LDL)
Comtex SmarTrend(R) - Wed Feb 10, 9:41AM CST
SmarTrend identified a Downtrend for Lydall (NYSE:LDL) on January 5th, 2016 at $33.00. In approximately 1 month, Lydall has returned 20.11% as of today's recent price of $26.36.
LDL: 43.05 (+0.04)

Lydall Shares Down 17.0% Since SmarTrend's Sell Call (LDL)
Comtex SmarTrend(R) - Tue Feb 02, 3:28PM CST
SmarTrend identified a Downtrend for Lydall (NYSE:LDL) on January 5th, 2016 at $33.00. In approximately 4 weeks, Lydall has returned 16.96% as of today's recent price of $27.40.
LDL: 43.05 (+0.04)

Shares of LDL Down 17.0% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Tue Feb 02, 2:16PM CST
SmarTrend identified a Downtrend for Lydall (NYSE:LDL) on January 5th, 2016 at $33.00. In approximately 4 weeks, Lydall has returned 16.96% as of today's recent price of $27.40.
LDL: 43.05 (+0.04)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Govee Stirs Halloween Chills with New Sarah Gellar Ad

Updated Category News Views 4

Lighting Up Halloween the Hollywood Way When it comes to Halloween, folks go nuts driving up the thrill factor at home, and boy, has Govee nailed it this time around. They've dragged Sarah Michelle Gellar into their spooky mix, transforming homes into eerie masterpieces. And let's face it, who better than the 'Buffy the Vampire Slayer' herself to stir those spine-tingling...

Continue Reading
The Real Cost of Cabinet Decisions: Refinish or Replace?

Updated Category News Views 3

Uncovering the Truth Behind Cabinet Decisions When it comes to sprucing up a kitchen, most folks overlook what's hanging on their walls already: those tired old cabinets. Now, are you looking at chucking them out the window for brand-new ones, or can a fresh coat of paint breathe new life into them? Well, that's where Melvin Jones, a painting virtuoso from Lexington,...

Continue Reading
Ractigen's Breakthrough in DMD: RNA Activates Utrophin

Updated Category News Views 3

Ractigen's New Fight Against Duchenne: A Personal Take When it comes to biotech advancements, I've seen enough breakthroughs to not get swayed easily. But Ractigen Therapeutics presenting their first-in-human data on RNA activation for Duchenne Muscular Dystrophy (DMD) kind of demands your attention. Folks, they're talking about a potential shift in handling this brutal...

Continue Reading
Aetna's 2027 Medicare Plans: Comprehensive Outlook

Updated Category News Views 3

Unpacking Aetna's Medicare Strategy for 2027 Look, if there's one thing you should keep tabs on, it's how Aetna isn't just coasting by in the healthcare arena. These folks are pushing forward with new options for 2027 that prove they're serious about making healthcare not just accessible, but affordable across the board. Aetna, backed by CVS Health (NYSE: CVS), is making...

Continue Reading
Kal Plastics Showcases at Design-2-Part Expo

Updated Category News Views 3

Kal Plastics Steps into the Limelight There's a buzz in the air, and it's all about Kal Plastics getting ready to strut their stuff at the Southern California Design-2-Part Show. Now, most folks probably don't spend their nights dreaming about thermoforming and pressure forming, but these guys sure make a case for it. They’ve got their eyes on impressing the crowd with...

Continue Reading
Honeywell's Supply Line Snags Bait Class Action Risk

Updated Category News Views 8

Stepping into the chaos of the stock market sometimes feels like opening Pandora's box—just when you think you've seen it all, something new tumbles out. This time around, it's Honeywell Aerospace (NasdaqGS: HONA) playing catch with hot coals, and a burning class-action lawsuit smolders in the air. Deadline Looms for Investors in Class Action Heads up, folks! If you've...

Continue Reading
Venice's Climate Challenge: Rising Seas, Sinking Lands

Updated Category News Views 3

Sea Rise Isn’t Just a Statistics Problem The ordeal of rising seas isn't just about staring at numbers in some spreadsheet, it's a real-world gut punch that's knocking at Venice's door. This city, known for its stunning architecture and winding canals, now serves as the poster child for what happens when Mother Nature and human errors leave a place on the brink of...

Continue Reading
Trading Platforms Poised for Billions by 2031

Updated Category News Views 4

Forecasts and Fierce Digital Landscapes Just when you thought the online trading realm was getting saturated, the numbers are making it clear: there’s still room for growth—even explosive growth. The online trading platform market is eyeing a hike, jumping from a $11.65 billion valuation in 2025 to a projected $18.18 billion by 2031, according to Mordor Intelligence....

Continue Reading
Vatrer Power: Lithium Batteries Revolutionize Golf Carts

Updated Category News Views 2

The humdrum world of golf carts just got a jolt of energy with lithium batteries entering the fray. Vatrer Power, the brain behind some nifty LiFePO4 lithium battery conversions, made some noise at this year's Golf Carting Expo & Dealer Summit in Charleston, South Carolina. Held at the North Charleston Convention Center, this trade show was the industry's premier...

Continue Reading

Top 5 Most Recently Viewed Articles

Investigation into Data Breach Claims for Tea App Users

Updated Category News Views 474

Understanding the Data Breach Involving Tea Dating Advice, Inc. The law firm Edelson Lechtzin LLP is delving into serious data privacy issues related to Tea Dating Advice, Inc., commonly referred to as the Tea app. This exploration follows the app's alarming announcement of a data breach that might have impacted many of its users. The Incident and Its Implications...

Continue Reading
Creatd, Inc. Shows Impressive Growth with Record EPS

Updated Category News Views 164

Significant Earnings Per Share Growth Creatd, Inc. has demonstrated remarkable progress by reporting earnings per share (EPS) that improved to $(0.13) for the three months ending September 30, marking a substantial recovery from $(0.50) in the previous year. This turnaround highlights the company's dedication to enhancing its financial performance. Stellar Revenue...

Continue Reading
E. Coli Outbreak and Its Impact on McDonald's Sales Strategy

Updated Category News Views 254

Impact of E. Coli Outbreak on McDonald's Sales The recent E. coli outbreak associated with McDonald's Quarter Pounder hamburgers has raised concerns among investors regarding potential disruptions in the company's near-term sales. As McDonald's prepares to report its third-quarter results, all eyes are on how this food safety incident might affect revenue. Alarming...

Continue Reading
Understanding Middlefield Canadian Income PCC's Net Asset Valuation

Updated Category News Views 138

An Overview of Middlefield Canadian Income PCC Middlefield Canadian Income PCC is a unique financial entity designed to offer diversified investment opportunities. It operates as a protected cell company, which allows it to manage separate pools of assets while limiting liability exposure. With its roots in Jersey, this company has crafted a niche for itself within the...

Continue Reading
FuboTV's Strategic Alliance with Disney Forms a New Streaming Giant

Updated Category News Views 277

FuboTV and Disney Join Forces for Enhanced Streaming FuboTV Inc. (NYSE: FUBO) has recently made significant waves in the streaming industry by securing an agreement with The Walt Disney Company (NYSE: DIS). This partnership is set to merge Disney's Hulu + Live TV with Fubo, effectively crafting a new entity that will harness the strengths of both platforms. This...

Continue Reading